Why Ra Pharmaceuticals Is Skyrocketing Today
Shares of Ra Pharmaceuticals (NASDAQ: RARX), a clinical-stage biopharmaceutical company focused on rare diseases, jumped 101% as of 10:56 a.m. EST on Thursday. The huge move is a response to the news that Ra has agreed to be acquired by UCB (NASDAQOTH: UCBJF), a global biopharmaceutical company based in Belgium.
Here are the key terms of the acquisition:
Image source: Getty Images.
Source Fool.com
